From the ∗Department of Psychiatry
†Department of Psychology, Université de Montréal
‡Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal (CRIR), Notre-Dame Hospital, CIUSSS du Centre-Sud-de-l'Île-de-Montréal
§Centre d'excellence en électroconvulsivothérapie du Québec (CEECTQ), CIUSSS de l'Est-de-l'Île-de-Montréal
∥Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal (IUSMM), CIUSSS de l'Est-de-l'Île-de-Montréal
¶Institut Universitaire en Santé Mentale de Québec (IUSMQ)
#Bureau d'information et d'études en santé des populations, Institut national de santé publique du Quebec City, Quebec, Canada.
Received for publication August 1, 2019; accepted July 31, 2020.
Reprints: Marilyne Landry, MD, MSc, Department of Psychiatry, Université de Montréal, 2900 Boulevard Edouard-Montpetit, Montreal, Qc, Canada H3T 1J4 (e-mail: [email protected]).
The authors have no conflicts of interest to report. In the last 3 years, S.P. has been a holder of grants from Otsuka Pharmaceuticals and HLS Therapeutics, which are unrelated to the current study.
Supplemental digital contents are available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.ectjournal.com).
